Vicarious Surgical (RBOT) Cash from Operations (2020 - 2025)
Vicarious Surgical (RBOT) reported Cash from Operations of 10464000.0 for Q3 2025, up 17.53% year-over-year from 8902889.63 in Q3 2024, and up 22.67% on a QoQ basis from 13532000.0 in Q2 2025.
Vicarious Surgical (RBOT) has 6 years of Cash from Operations data on file, last reported at 10464000.0 in Q3 2025.
- Quarterly Cash from Operations rose 17.53% year-over-year to 10464000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 47552000.0 (up 4.01% YoY) and the FY2024 annual result came in at 49956000.0, up 19.82% from the prior year.
- Cash from Operations advanced to 10464000.0 in Q3 2025 per RBOT's latest filing, from 13532000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 4140000.0 in Q1 2021 and bottomed at 18570000.0 in Q1 2023.
- The 5-year median for Cash from Operations is 13532000.0 (2025), against an average of 12764947.37.
- The widest annual swing landed in 2021, when Cash from Operations plunged 3822.41%; it then soared 38.24% in 2023.
- Tracing RBOT's Cash from Operations over 5 years: stood at 9753000.0 in 2021, then slumped by 88.75% to 18409000.0 in 2022, then jumped by 38.24% to 11370000.0 in 2023, then declined by 3.68% to 11788000.0 in 2024, then advanced by 11.23% to 10464000.0 in 2025.
- Per Business Quant, the three latest RBOT Cash from Operations figures stand at 10464000.0 (Q3 2025), 13532000.0 (Q2 2025), and 11768000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.74 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 220.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 525.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 335.40 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.46 Mn |
| Sep 30, 2025 | -10.46 Mn |
| Jun 30, 2025 | -13.53 Mn |
| Jun 30, 2025 | -13.53 Mn |
| Mar 31, 2025 | -11.77 Mn |
| Mar 31, 2025 | -11.77 Mn |
| Dec 31, 2024 | -11.79 Mn |
| Dec 31, 2024 | -11.79 Mn |
| Sep 30, 2024 | -12.69 Mn |
| Sep 30, 2024 | -12.69 Mn |
| Jun 30, 2024 | -11.02 Mn |
| Jun 30, 2024 | -11.02 Mn |
| Mar 31, 2024 | -14.46 Mn |
| Mar 31, 2024 | -14.46 Mn |
| Dec 31, 2023 | -11.37 Mn |
| Dec 31, 2023 | -11.37 Mn |
| Sep 30, 2023 | -17.28 Mn |
| Sep 30, 2023 | -17.28 Mn |
| Jun 30, 2023 | -15.08 Mn |
| Jun 30, 2023 | -15.08 Mn |
| Mar 31, 2023 | -18.57 Mn |
| Mar 31, 2023 | -18.57 Mn |
| Dec 31, 2022 | -18.41 Mn |
| Dec 31, 2022 | -18.41 Mn |
| Sep 30, 2022 | -13.84 Mn |
| Sep 30, 2022 | -13.84 Mn |
| Jun 30, 2022 | -14.20 Mn |
| Jun 30, 2022 | -14.20 Mn |
| Mar 31, 2022 | -14.77 Mn |
| Mar 31, 2022 | -14.77 Mn |
| Dec 31, 2021 | -9.75 Mn |
| Dec 31, 2021 | -9.75 Mn |
| Sep 30, 2021 | -13.64 Mn |
| Sep 30, 2021 | -13.64 Mn |
| Jun 30, 2021 | -5.76 Mn |
| Jun 30, 2021 | -5.76 Mn |
| Mar 31, 2021 | -4.14 Mn |
| Mar 31, 2021 | -4.14 Mn |
| Dec 31, 2020 | -427,301.00 |
| Dec 31, 2020 | -427,301.00 |
| Sep 30, 2020 | -347,771.00 |
| Sep 30, 2020 | -347,771.00 |